(GIB) CGI - Ratings and Ratios
IT Consulting, Integration, Software Solutions, Managed Services, Cybersecurity
Dividends
| Dividend Yield | 0.48% |
| Yield on Cost 5y | 0.58% |
| Yield CAGR 5y | 2.44% |
| Payout Consistency | 100.0% |
| Payout Ratio | 5.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.9% |
| Value at Risk 5%th | 34.0% |
| Relative Tail Risk | -1.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -28.42 |
| CAGR/Max DD | 0.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.399 |
| Beta | 0.556 |
| Beta Downside | 0.519 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.52% |
| Mean DD | 8.86% |
| Median DD | 6.49% |
Description: GIB CGI October 16, 2025
CGI Inc. (NYSE:GIB) is a global provider of information technology and business process services, offering a broad portfolio that spans strategic IT consulting, systems integration, software development, application modernization, DevOps, digital and intelligent automation, cybersecurity, advanced analytics, and managed infrastructure. The firm serves a diversified client base across government, financial services, health care, utilities, communications, energy, manufacturing, insurance, life sciences, retail, and logistics sectors, operating in North America, Europe, Asia-Pacific and other international markets.
Key recent metrics show CGI generated approximately $14.5 billion in revenue for FY 2023, reflecting a modest 5% year-over-year increase driven by higher demand for cloud migration and cybersecurity services. The company posted an operating margin of roughly 10.5% and free cash flow of $1.2 billion, supporting a backlog of about $10 billion that underpins near-term revenue visibility. Macro-level drivers include accelerating digital transformation spending (global IT services market expected to grow ~6% CAGR through 2028) and sustained government IT budgets, which historically provide a recession-resilient revenue stream for firms like CGI.
For a deeper quantitative assessment of CGI’s valuation relative to peers, the ValueRay platform offers a data-driven dashboard worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (1.66b TTM) > 0 and > 6% of Revenue (6% = 954.8m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -1.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -0.31% (prev 8.64%; Δ -8.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 2.23b > Net Income 1.66b (YES >=105%, WARN >=100%) |
| Net Debt (3.61b) to EBITDA (2.87b) ratio: 1.26 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (221.9m) change vs 12m ago -3.50% (target <= -2.0% for YES) |
| Gross Margin 20.67% (prev 16.39%; Δ 4.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 87.90% (prev 87.96%; Δ -0.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 22.38 (EBITDA TTM 2.87b / Interest Expense TTM 105.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.22
| (A) -0.00 = (Total Current Assets 5.05b - Total Current Liabilities 5.10b) / Total Assets 19.52b |
| (B) 0.38 = Retained Earnings (Balance) 7.43b / Total Assets 19.52b |
| (C) 0.13 = EBIT TTM 2.35b / Avg Total Assets 18.10b |
| (D) 1.07 = Book Value of Equity 9.93b / Total Liabilities 9.24b |
| Total Rating: 3.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.34
| 1. Piotroski 7.0pt |
| 2. FCF Yield 6.43% |
| 3. FCF Margin 12.56% |
| 4. Debt/Equity 0.43 |
| 5. Debt/Ebitda 1.26 |
| 6. ROIC - WACC (= 5.82)% |
| 7. RoE 16.37% |
| 8. Rev. Trend 93.60% |
| 9. EPS Trend 90.96% |
What is the price of GIB shares?
Over the past week, the price has changed by +3.34%, over one month by +7.32%, over three months by -3.85% and over the past year by -18.70%.
Is GIB a buy, sell or hold?
- Strong Buy: 4
- Buy: 9
- Hold: 1
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the GIB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 92.6 | 1.2% |
| Analysts Target Price | 92.6 | 1.2% |
| ValueRay Target Price | 86.5 | -5.4% |
GIB Fundamental Data Overview November 25, 2025
P/E Trailing = 16.795
P/E Forward = 13.8504
P/S = 1.2323
P/B = 2.6242
P/EG = 1.5647
Beta = 0.362
Revenue TTM = 15.91b CAD
EBIT TTM = 2.35b CAD
EBITDA TTM = 2.87b CAD
Long Term Debt = 2.79b CAD (from longTermDebt, last quarter)
Short Term Debt = 1.02b CAD (from shortTermDebt, last quarter)
Debt = 4.47b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.61b CAD (from netDebt column, last quarter)
Enterprise Value = 31.07b CAD (27.46b + Debt 4.47b - CCE 867.9m)
Interest Coverage Ratio = 22.38 (Ebit TTM 2.35b / Interest Expense TTM 105.0m)
FCF Yield = 6.43% (FCF TTM 2.00b / Enterprise Value 31.07b)
FCF Margin = 12.56% (FCF TTM 2.00b / Revenue TTM 15.91b)
Net Margin = 10.42% (Net Income TTM 1.66b / Revenue TTM 15.91b)
Gross Margin = 20.67% ((Revenue TTM 15.91b - Cost of Revenue TTM 12.62b) / Revenue TTM)
Gross Margin QoQ = 33.53% (prev 16.29%)
Tobins Q-Ratio = 1.59 (Enterprise Value 31.07b / Total Assets 19.52b)
Interest Expense / Debt = 0.53% (Interest Expense 23.7m / Debt 4.47b)
Taxrate = 26.13% (134.9m / 516.2m)
NOPAT = 1.74b (EBIT 2.35b * (1 - 26.13%))
Current Ratio = 0.99 (Total Current Assets 5.05b / Total Current Liabilities 5.10b)
Debt / Equity = 0.43 (Debt 4.47b / totalStockholderEquity, last quarter 10.28b)
Debt / EBITDA = 1.26 (Net Debt 3.61b / EBITDA 2.87b)
Debt / FCF = 1.81 (Net Debt 3.61b / FCF TTM 2.00b)
Total Stockholder Equity = 10.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.49% (Net Income 1.66b / Total Assets 19.52b)
RoE = 16.37% (Net Income TTM 1.66b / Total Stockholder Equity 10.13b)
RoCE = 18.18% (EBIT 2.35b / Capital Employed (Equity 10.13b + L.T.Debt 2.79b))
RoIC = 12.81% (NOPAT 1.74b / Invested Capital 13.55b)
WACC = 6.99% (E(27.46b)/V(31.93b) * Re(8.06%) + D(4.47b)/V(31.93b) * Rd(0.53%) * (1-Tc(0.26)))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.60%
[DCF Debug] Terminal Value 79.17% ; FCFE base≈1.98b ; Y1≈2.11b ; Y5≈2.54b
Fair Price DCF = 227.5 (DCF Value 44.36b / Shares Outstanding 195.0m; 5y FCF grow 7.39% → 3.0% )
EPS Correlation: 90.96 | EPS CAGR: 9.80% | SUE: 1.31 | # QB: 1
Revenue Correlation: 93.60 | Revenue CAGR: 6.99% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.28 | Chg30d=-0.002 | Revisions Net=-2 | Analysts=11
EPS current Year (2026-09-30): EPS=8.98 | Chg30d=-0.002 | Revisions Net=-3 | Growth EPS=+8.2% | Growth Revenue=+5.1%
EPS next Year (2027-09-30): EPS=9.71 | Chg30d=-0.083 | Revisions Net=-2 | Growth EPS=+8.2% | Growth Revenue=+3.4%
Additional Sources for GIB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle